ChartMill · Nov 16, 2026
Xtant Medical (NYSEARCA:XTNT) Slides After Q3 Revenue and EPS Miss Amid Strategic Review
XTNT Q3 revenue and EPS missed estimates, sending shares lower premarket as investors weigh the miss against a newly announced strategic review.

